These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2007322)

  • 1. Stable isotope studies of nicotine kinetics and bioavailability.
    Benowitz NL; Jacob P; Denaro C; Jenkins R
    Clin Pharmacol Ther; 1991 Mar; 49(3):270-7. PubMed ID: 2007322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical pharmacological study of subcutaneous nicotine.
    Le Houezec J; Jacob P; Benowitz NL
    Eur J Clin Pharmacol; 1993; 44(3):225-30. PubMed ID: 8491235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent studies of nicotine metabolism in humans.
    Jacob P; Benowitz NL; Shulgin AT
    Pharmacol Biochem Behav; 1988 May; 30(1):249-53. PubMed ID: 3174750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable isotope method for studying transdermal drug absorption: the nicotine patch.
    Benowitz NL; Chan K; Denaro CP; Jacob P
    Clin Pharmacol Ther; 1991 Sep; 50(3):286-93. PubMed ID: 1914363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of nicotine to cotinine studied by a dual stable isotope method.
    Benowitz NL; Jacob P
    Clin Pharmacol Ther; 1994 Nov; 56(5):483-93. PubMed ID: 7955812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers.
    Benowitz NL; Jacob P
    Clin Pharmacol Ther; 1993 Mar; 53(3):316-23. PubMed ID: 8453850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and absorption kinetics of nicotine following application of a transdermal system.
    Gupta SK; Benowitz NL; Jacob P; Rolf CN; Gorsline J
    Br J Clin Pharmacol; 1993 Sep; 36(3):221-7. PubMed ID: 9114908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
    Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
    Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans.
    Jacob P; Yu L; Wilson M; Benowitz NL
    Biol Mass Spectrom; 1991 May; 20(5):247-52. PubMed ID: 1883864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine-mecamylamine interactions.
    Zevin S; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2000 Jul; 68(1):58-66. PubMed ID: 10945316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose released and absolute bioavailability of nicotine from a nicotine vapor inhaler.
    Molander L; Lunell E; Andersson SB; Kuylenstierna F
    Clin Pharmacol Ther; 1996 Apr; 59(4):394-400. PubMed ID: 8612383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.
    Schneider NG; Olmstead RE; Franzon MA; Lunell E
    Clin Pharmacokinet; 2001; 40(9):661-84. PubMed ID: 11605715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cotinine effects on nicotine metabolism.
    Zevin S; Jacob P; Benowitz N
    Clin Pharmacol Ther; 1997 Jun; 61(6):649-54. PubMed ID: 9209247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine and carbon monoxide exposure from inhalation of cigarillo smoke.
    Koszowski B; Rosenberry ZR; Kanu A; Viray LC; Potts JL; Pickworth WB
    Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):7-14. PubMed ID: 26459155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid automated blood sampling system for pharmacokinetics studies of cigarette smoking.
    McKinney DL; Davies BD; Gogova M; Adams WM; Lewis W; Powell C; Iyer SS; Garnett WR; Karnes HT; Kobal G; Barr WH
    Nicotine Tob Res; 2010 Apr; 12(4):319-25. PubMed ID: 20142418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tobacco abstinence on the disposition kinetics and effects of nicotine.
    Lee BL; Benowitz NL; Jacob P
    Clin Pharmacol Ther; 1987 Apr; 41(4):474-9. PubMed ID: 3829584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute bioavailability of nicotine applied to different nasal regions.
    Johansson CJ; Olsson P; Bende M; Carlsson T; Gunnarsson PO
    Eur J Clin Pharmacol; 1991; 41(6):585-8. PubMed ID: 1815971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke.
    Melikian AA; Djordjevic MV; Hosey J; Zhang J; Chen S; Zang E; Muscat J; Stellman SD
    Nicotine Tob Res; 2007 Mar; 9(3):377-87. PubMed ID: 17365769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking.
    Sellers EM; Kaplan HL; Tyndale RF
    Clin Pharmacol Ther; 2000 Jul; 68(1):35-43. PubMed ID: 10945314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of ammonia on the deposition, retention, and absorption of nicotine in humans while smoking.
    Seeman JI
    Chem Res Toxicol; 2007 Mar; 20(3):326-43. PubMed ID: 17316028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.